BioWorld - Wednesday, February 11, 2026

BioWorld Science

Aug. 16, 2018

View Archived Issues

Microbiome affects rotavirus vaccine immunogenicity

Read More

TAC versus CAR

Read More

RAPTA-T pretreatment enhances tumor vascular function and cisplatin uptake in pleural mesothelioma

Read More

Discovery of a biomarker that correlates with psychopathy and cognition in schizophrenia

Read More

Identification of a gene that drives progression and metastases in KRAS-driven lung cancer

Read More

Preclinical studies identify a potential drug target for the treatment of neuroblastoma

Read More

First patient treated in Escalier Biosciences' phase I/IIa study of ESR-114

Read More

Entasis announces positive topline phase II data for ETX-2514 plus sulbactam in patients with cUTI

Read More

Brain immune cells mediate arthritic joint pain

Read More

IND approval received in China for phase Ib/III study of CAN-017 as treatment of ESCC

Read More

Hefei Institutes of Physical Sciences divulges EZH2 inhibitors

Read More

Proteasome inhibitors patented by Chengdu Origin Biotechnology

Read More

Shanghai Longwood Biopharmaceuticals identifies hepatitis B caspid assembly inhibitors

Read More

Nuclear receptor ROR-gamma inverse agonists discovered at Genfit

Read More

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical describe TLR7 agonists

Read More

First patients dosed in phase I/II study of TLC-590 for postsurgical pain management

Read More

BHV-0223 reduces anxiety in proof-of-concept trial

Read More

Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months

Read More

Phase II trial of AG-013 in oral mucositis resumes

Read More

Cabotegravir/rilpivirine regimen shows noninferiority to three-drug regimen for HIV infection

Read More